REALISTIC: Protocol for an observational study in high risk patients switched from higher doses of other statins to Crestor [rosuvastatin] on the percentage of patients reaching the new EAS [European Atherosclerosis Society] LDL-C [low-density lipoprotein cholesterol] target goal

Trial Profile

REALISTIC: Protocol for an observational study in high risk patients switched from higher doses of other statins to Crestor [rosuvastatin] on the percentage of patients reaching the new EAS [European Atherosclerosis Society] LDL-C [low-density lipoprotein cholesterol] target goal

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Aug 2011

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Acronyms REALISTIC
  • Sponsors AstraZeneca
  • Most Recent Events

    • 07 Feb 2008 Status changed from in progress to completed (source: ClinicalTrials.gov).
    • 03 Nov 2006 Status change
    • 27 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top